Clinical Trial Update: Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence [Phase 3]

View source ↗

Summary

Phase 3 imaging trial evaluating the safety and diagnostic performance of the 18F rhPSMA-7.3 PET ligand in suspected prostate cancer recurrence has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F rhPSMA-7.3 PET ligand (18F-rhPSMA-7.3 PET ligand)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-02-26